Derick R J, Evans J, Baker N D
Havener Eye Center, Ohio State University College of Medicine, Columbus, OH, USA.
Ophthalmic Surg Lasers. 1998 Sep;29(9):707-13.
To compare the results of combined phacoemulsification and trabeculectomy (PEM/TRAB) plus mitomycin-C with those of trabeculectomy alone (TRAB) plus mitomycin-C.
The authors retrospectively reviewed 42 eyes in 38 consecutive patients who underwent combined PEM/TRAB with mitomycin-C. An age-matched control group of 42 patients who underwent TRAB with mitomycin-C during the same time period was randomly selected from 248 consecutive patients. All patients had a minimum of 12 months of follow-up.
Mean preoperative intraocular pressure (IOP) and number of glaucoma medications were similar for the two groups (22.8 +/- 6.9 mm Hg vs 22.9 +/- 6.8 mm Hg, 2.12 +/- 0.8 vs 2.26 +/- 1.0 medications, combined PEM/TRAB vs TRAB, respectively). Postoperative IOP was significantly lower at all follow-up intervals. At final follow-up after a mean of 21.8 +/- 6.0 months, IOP averaged 13.9 +/- 5.1 mm Hg in the PEM/TRAB group and 12.3 +/- 4.7 mm Hg in the TRAB group. Bleb survival was excellent in both groups, although slightly higher in the TRAB group (37 of 42 PEM/TRAB vs 41 of 42 TRAB). Both groups required significantly fewer glaucoma medications at final follow-up (0.38 +/- 0.6 vs 0.5 +/- 0.8, PEM/TRAB vs TRAB). Complications were similar between the two groups.
The success rate for combined PEM/TRAB appears to approach that of TRAB alone.
比较超声乳化白内障吸除联合小梁切除术(PEM/TRAB)加丝裂霉素C与单纯小梁切除术(TRAB)加丝裂霉素C的治疗效果。
作者回顾性分析了38例连续接受PEM/TRAB联合丝裂霉素C治疗的患者的42只眼。同期从248例连续患者中随机选取42例年龄匹配的患者作为对照组,这些患者接受了TRAB联合丝裂霉素C治疗。所有患者均至少随访12个月。
两组患者术前平均眼压(IOP)和青光眼药物使用数量相似(PEM/TRAB组与TRAB组分别为22.8±6.9 mmHg对22.9±6.8 mmHg,2.12±0.8对2.26±1.0种药物)。在所有随访期间,术后眼压均显著降低。平均随访21.8±6.0个月后的最终随访时,PEM/TRAB组眼压平均为13.9±5.1 mmHg,TRAB组为12.3±4.7 mmHg。两组滤过泡存活率均良好,尽管TRAB组略高(PEM/TRAB组42眼中的37眼对TRAB组42眼中的41眼)。在最终随访时,两组所需的青光眼药物均显著减少(PEM/TRAB组对TRAB组为0.38±0.6对0.5±0.8)。两组并发症相似。
PEM/TRAB联合手术的成功率似乎接近单纯TRAB手术。